Trials / Active Not Recruiting

Active Not RecruitingNCT06226714

A Clinical Trial of ACYW135 Group Meningococcal Polysaccharide Conjugate Vaccine (CRM197 Vector) in 18-59 Year Olds

A Randomized, Blinded, Peer-controlled Clinical Trial to Evaluate the Safety and Immunogenicity of ACYW135 Group Meningococcal Polysaccharide Conjugate Vaccine (CRM197 Vector) in a Population Aged 18-59 Years

Status: Active Not Recruiting
Phase: Phase 3
Study type: Interventional
Enrollment: 840 (actual)

Sponsor: CanSino Biologics Inc. · Industry
Sex: All
Age: 18 Years – 59 Years
Healthy volunteers: Accepted

Summary

This is a randomized, observer-blind, peer-controlled study. There will be 2 treatment groups, screened subjects were given study numbers in the order of enrollment and randomly assigned to the test and control groups in a 1:1 ratio. Subjects were required to complete a 1-dose immunization program with 0.5 ml of vaccine in both the test and control groups.

Conditions

Meningococcal Meningitis

Interventions

Type	Name	Description
BIOLOGICAL	MCV4	1 dose of MCV4 on Day 0
BIOLOGICAL	MPSV4	1 dose of MSPV4 on Day 0

Timeline

Start date: 2024-03-01
Primary completion: 2024-09-26
Completion: 2025-08-01
First posted: 2024-01-26
Last updated: 2025-07-29

Locations

3 sites across 1 country: China

Source: ClinicalTrials.gov record NCT06226714. Inclusion in this directory is not an endorsement.